Havel V

Department of Chemistry and the Zuckerman Mind Brain Behavior Institute, Columbia University, New York, NY, USA.

4 papers · 2 preprints · ORCID

ArticleIbogaine

Development and validation of a UPLC-MS/MS method for real-time neuropharmacokinetic monitoring of iboga alkaloids in rat brain.

McIntosh S, Maldonado I, Smith NC +5

Europe PMC2026
PreprintIbogaine

Oxa-noribogaine reduces alcohol drinking through aversion learning and by altering glutamatergic activity in the mPFC

Meinhardt M, Skorodumov I, Walter F +21

Europe PMC2026
ArticleIbogaine

Deciphering Ibogaine's Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses.

Hwu C, Havel V, Westergaard X +20

Europe PMC2026
PreprintIbogaine

Deciphering Ibogaine’s Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses

Hwu C, Havel V, Westergaard X +18

Europe PMC2025
ArticleIbogaine

Oxa-Iboga alkaloids lack cardiac risk and disrupt opioid use in animal models.

Havel V, Kruegel AC, Bechand B +18

Europe PMC2024
ArticlePsilocybin

Structural pharmacology and therapeutic potential of 5-methoxytryptamines.

Warren AL, Lankri D, Cunningham MJ +10

Europe PMC2024